Literature DB >> 27428523

Dexmedetomidine: what next?

Michael C Reade1.   

Abstract

Entities:  

Year:  2016        PMID: 27428523      PMCID: PMC4930513          DOI: 10.21037/atm.2016.06.10

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  11 in total

1.  The efficacy of continuous infusion of low dose dexmedetomidine for postoperative patients recovering in general wards.

Authors:  Hiroko Iwakiri; Yutaka Oda; Akira Asada; Makoto Ozaki
Journal:  Eur J Anaesthesiol       Date:  2012-05       Impact factor: 4.330

Review 2.  Sedation and delirium in the intensive care unit.

Authors:  Michael C Reade; Simon Finfer
Journal:  N Engl J Med       Date:  2014-01-30       Impact factor: 91.245

3.  Dexmedetomidine versus midazolam for the sedation of patients with non-invasive ventilation failure.

Authors:  Zhao Huang; Yu-sheng Chen; Zi-li Yang; Ji-yun Liu
Journal:  Intern Med       Date:  2012-09-01       Impact factor: 1.271

4.  Effects of dexmedetomidine on anesthesia recovery period and postoperative cognitive function of patients after robot-assisted laparoscopic radical cystectomy.

Authors:  Lingling Ding; Hong Zhang; Weidong Mi; Tao Wang; Yan He; Xu Zhang; Xin Ma; Hongzhao Li
Journal:  Int J Clin Exp Med       Date:  2015-07-15

5.  Clonidine Restores Pressor Responsiveness to Phenylephrine and Angiotensin II in Ovine Sepsis.

Authors:  Yugeesh R Lankadeva; Lindsea C Booth; Junko Kosaka; Roger G Evans; Luc Quintin; Rinaldo Bellomo; Clive N May
Journal:  Crit Care Med       Date:  2015-07       Impact factor: 7.598

6.  Neuroprotective Effects of Dexmedetomidine Against Hypoxia-Induced Nervous System Injury are Related to Inhibition of NF-κB/COX-2 Pathways.

Authors:  Wanying Pan; Lin Lin; Nan Zhang; Fuli Yuan; Xiaoxiao Hua; Yueting Wang; Liqiu Mo
Journal:  Cell Mol Neurobiol       Date:  2015-12-18       Impact factor: 5.046

7.  Neuroprotection by the alpha2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia.

Authors:  J Jolkkonen; K Puurunen; J Koistinaho; R Kauppinen; A Haapalinna; L Nieminen; J Sivenius
Journal:  Eur J Pharmacol       Date:  1999-05-07       Impact factor: 4.432

8.  Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.

Authors:  Richard R Riker; Yahya Shehabi; Paula M Bokesch; Daniel Ceraso; Wayne Wisemandle; Firas Koura; Patrick Whitten; Benjamin D Margolis; Daniel W Byrne; E Wesley Ely; Marcelo G Rocha
Journal:  JAMA       Date:  2009-02-02       Impact factor: 56.272

9.  Clonidine and dexmedetomidine increase the pressor response to norepinephrine in experimental sepsis: a pilot study.

Authors:  A Geloen; K Chapelier; A Cividjian; E Dantony; M Rabilloud; C N May; L Quintin
Journal:  Crit Care Med       Date:  2013-12       Impact factor: 7.598

10.  Dexmedetomidine is neuroprotective in an in vitro model for traumatic brain injury.

Authors:  Marc Schoeler; Philip D Loetscher; Rolf Rossaint; Astrid V Fahlenkamp; Georg Eberhardt; Steffen Rex; Joachim Weis; Mark Coburn
Journal:  BMC Neurol       Date:  2012-04-11       Impact factor: 2.474

View more
  1 in total

Review 1.  Brainstem dysfunction in critically ill patients.

Authors:  Sarah Benghanem; Aurélien Mazeraud; Eric Azabou; Vibol Chhor; Cassia Righy Shinotsuka; Jan Claassen; Benjamin Rohaut; Tarek Sharshar
Journal:  Crit Care       Date:  2020-01-06       Impact factor: 9.097

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.